$CDXS Cashflow Statement | Understand Stock

$CDXS

$1.26 -$0.02 (1.56%) Close

$CDXS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Depreciation and amortization
Reduction in the carrying amount of right-of-use assets
Stock-based compensation
Provision (recovery) for credit losses
Asset impairment and other charges
Impairment of investment in non-marketable securities
Equity securities earned from research and development activities
Unrealized gain on non-marketable securities ($0, $0, and ($208) from a related party)
Non-cash interest expense
Amortization of discount on short-term investments
Other non-cash items
Changes in operating assets and liabilities:
Financial assets
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued compensation and other accrued liabilities
Other long-term liabilities
Deferred revenue
Net cash used in operating activities
Investing activities:
Purchase of property and equipment
Proceeds from sale of property and equipment
Proceeds from sale of investment securities
Purchases of short-term investments
Proceeds from maturity of short-term investments
Proceeds from sale of short-term investments
Investment in non-marketable securities
Net cash provided by (used in) investing activities

Financing activities:
Proceeds from exercises of stock options
Proceeds from issuance of stock under employee stock purchase plan
Proceeds from issuance of common stock in connection with equity sales agreements
Costs incurred in connection with equity financing
Proceeds from issuance of common stock in connection with private offering
Payments of lease obligations - Finance leases
Recovery of short swing profit
Costs incurred in connection with equity sales agreements
Proceeds from long-term debt
Payment of debt issuance costs
Taxes paid related to net share settlement of equity awards
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid
Supplemental non-cash investing and financing activities:
Capital expenditures incurred but not yet paid
Cash reconciliation:
Cash and cash equivalents
Restricted cash, current and non-current

Comments